Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A. Human Coagulation Factor VIII concentrated from donated blood plasma (Aafact or Alphanate, Monoclate-P?), or alternatively recombinant Human Coagulation Factor VIII can be given to hemophiliacs to restore hemostasis.
This report elaborates on the current development of the Human Coagulation Factor VIII industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Baxter
Bayer
CSL
Pfizer
Grifols
Biogen
Octapharma
NovoNordisk
Greencross
Kedrion
BPL
Hualan Bio
RAAS
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Recombinant Factor VIII
Plasma-derived Factor VIII
Application:
Hemophilia A
Spontanous / Trauma
Surgical
Other
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Human Coagulation Factor VIII Industry Overview
-
1.1.1 Human Coagulation Factor VIII Market Scope and Market Segments
-
1.1.2 Human Coagulation Factor VIII Industry Characteristics
-
1.1.3 Global and China Human Coagulation Factor VIII Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Human Coagulation Factor VIII Production Value and Growth Rate (2017-2028)
-
1.2 Global Human Coagulation Factor VIII Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Recombinant Factor VIII
-
1.2.2 Plasma-derived Factor VIII
-
1.3 Global Human Coagulation Factor VIII Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Hemophilia A
-
1.3.2 Spontanous / Trauma
-
1.3.3 Surgical
-
1.3.4 Other
-
1.4 Market Analysis by Region
-
1.4.1 North America Human Coagulation Factor VIII Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Human Coagulation Factor VIII Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Human Coagulation Factor VIII Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Human Coagulation Factor VIII Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Human Coagulation Factor VIII Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Human Coagulation Factor VIII Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Human Coagulation Factor VIII Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Human Coagulation Factor VIII Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Human Coagulation Factor VIII Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Human Coagulation Factor VIII Industry Porter's Five Forces Model Analysis
-
2.2.3 Human Coagulation Factor VIII Industry PEST Analysis
-
2.3 Human Coagulation Factor VIII Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Human Coagulation Factor VIII Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Human Coagulation Factor VIII Industry
Chapter 3 Global and China Human Coagulation Factor VIII Market, by Manufacturer
-
3.1 Global and China Human Coagulation Factor VIII Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Human Coagulation Factor VIII Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Human Coagulation Factor VIII Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Human Coagulation Factor VIII Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Human Coagulation Factor VIII Market Top 3 Players
Chapter 4 Global and China Human Coagulation Factor VIII Market, by Type (2017-2028)
-
4.1 Human Coagulation Factor VIII Market Trend, by Type
-
4.2 Global Human Coagulation Factor VIII Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Human Coagulation Factor VIII Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Human Coagulation Factor VIII Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Human Coagulation Factor VIII Price Trend, by Type (2017-2028)
-
4.3 China Human Coagulation Factor VIII Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Human Coagulation Factor VIII Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Human Coagulation Factor VIII Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Human Coagulation Factor VIII Price Trend, by Type (2017-2028)
Chapter 5 Global and China Human Coagulation Factor VIII Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Human Coagulation Factor VIII Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Human Coagulation Factor VIII Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Human Coagulation Factor VIII Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Human Coagulation Factor VIII Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Human Coagulation Factor VIII Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Human Coagulation Factor VIII Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Human Coagulation Factor VIII Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Human Coagulation Factor VIII Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Human Coagulation Factor VIII Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Human Coagulation Factor VIII Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Human Coagulation Factor VIII Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Human Coagulation Factor VIII Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Human Coagulation Factor VIII Market Analysis
-
7.1 North America Human Coagulation Factor VIII Market, by Type
-
7.2 North America Human Coagulation Factor VIII Market, by Application
-
7.3 North America Human Coagulation Factor VIII Market Analysis and Forecast, by Country
-
7.3.1 United States Human Coagulation Factor VIII Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Human Coagulation Factor VIII Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Human Coagulation Factor VIII Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Human Coagulation Factor VIII Market Analysis
-
8.1 Europe Human Coagulation Factor VIII Market, by Type
-
8.2 Europe Human Coagulation Factor VIII Market, by Application
-
8.3 Europe Human Coagulation Factor VIII Market Analysis and Forecast, by Country
-
8.3.1 Germany Human Coagulation Factor VIII Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Human Coagulation Factor VIII Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Human Coagulation Factor VIII Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Human Coagulation Factor VIII Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Human Coagulation Factor VIII Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Human Coagulation Factor VIII Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Human Coagulation Factor VIII Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Human Coagulation Factor VIII Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Human Coagulation Factor VIII Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Human Coagulation Factor VIII Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Human Coagulation Factor VIII Market Analysis
-
9.1 APAC Human Coagulation Factor VIII Market, by Type
-
9.2 APAC Human Coagulation Factor VIII Market, by Application
-
9.3 APAC Human Coagulation Factor VIII Market Analysis and Forecast, by Country
-
9.3.1 China Human Coagulation Factor VIII Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Human Coagulation Factor VIII Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Human Coagulation Factor VIII Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Human Coagulation Factor VIII Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Human Coagulation Factor VIII Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Human Coagulation Factor VIII Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Human Coagulation Factor VIII Market Analysis
-
10.1 Latin America, Middle East and Africa Human Coagulation Factor VIII Market, by Type
-
10.2 Latin America, Middle East and Africa Human Coagulation Factor VIII Market, by Application
-
10.3 Latin America, Middle East and Africa Human Coagulation Factor VIII Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Human Coagulation Factor VIII Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Human Coagulation Factor VIII Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Human Coagulation Factor VIII Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Human Coagulation Factor VIII Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Human Coagulation Factor VIII Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Human Coagulation Factor VIII Company Profiles
-
11.1 Baxter
-
11.1.1 Baxter Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Baxter Human Coagulation Factor VIII Product Profiles, Application and Specification
-
11.1.3 Baxter Human Coagulation Factor VIII Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Bayer
-
11.2.1 Bayer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Bayer Human Coagulation Factor VIII Product Profiles, Application and Specification
-
11.2.3 Bayer Human Coagulation Factor VIII Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 CSL
-
11.3.1 CSL Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 CSL Human Coagulation Factor VIII Product Profiles, Application and Specification
-
11.3.3 CSL Human Coagulation Factor VIII Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Pfizer
-
11.4.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Pfizer Human Coagulation Factor VIII Product Profiles, Application and Specification
-
11.4.3 Pfizer Human Coagulation Factor VIII Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Grifols
-
11.5.1 Grifols Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Grifols Human Coagulation Factor VIII Product Profiles, Application and Specification
-
11.5.3 Grifols Human Coagulation Factor VIII Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Biogen
-
11.6.1 Biogen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Biogen Human Coagulation Factor VIII Product Profiles, Application and Specification
-
11.6.3 Biogen Human Coagulation Factor VIII Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Octapharma
-
11.7.1 Octapharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Octapharma Human Coagulation Factor VIII Product Profiles, Application and Specification
-
11.7.3 Octapharma Human Coagulation Factor VIII Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 NovoNordisk
-
11.8.1 NovoNordisk Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 NovoNordisk Human Coagulation Factor VIII Product Profiles, Application and Specification
-
11.8.3 NovoNordisk Human Coagulation Factor VIII Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 Greencross
-
11.9.1 Greencross Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 Greencross Human Coagulation Factor VIII Product Profiles, Application and Specification
-
11.9.3 Greencross Human Coagulation Factor VIII Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.10 Kedrion
-
11.10.1 Kedrion Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.10.2 Kedrion Human Coagulation Factor VIII Product Profiles, Application and Specification
-
11.10.3 Kedrion Human Coagulation Factor VIII Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.11 BPL
-
11.11.1 BPL Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.11.2 BPL Human Coagulation Factor VIII Product Profiles, Application and Specification
-
11.11.3 BPL Human Coagulation Factor VIII Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.12 Hualan Bio
-
11.12.1 Hualan Bio Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.12.2 Hualan Bio Human Coagulation Factor VIII Product Profiles, Application and Specification
-
11.12.3 Hualan Bio Human Coagulation Factor VIII Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.13 RAAS
-
11.13.1 RAAS Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.13.2 RAAS Human Coagulation Factor VIII Product Profiles, Application and Specification
-
11.13.3 RAAS Human Coagulation Factor VIII Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Human Coagulation Factor VIII Industry Investment Prospect and Risk Assessment
-
12.1 Human Coagulation Factor VIII Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Human Coagulation Factor VIII Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Human Coagulation Factor VIII Sales Volume and Growth Rate (2017-2028)
-
Figure China Human Coagulation Factor VIII Sales Volume and Growth Rate (2017-2028)
-
Figure Global Human Coagulation Factor VIII Production Value and Growth Rate (2017-2028)
-
Figure China Human Coagulation Factor VIII Production Value and Growth Rate (2017-2028)
-
Figure Global Human Coagulation Factor VIII Market Size and Growth Rate of Recombinant Factor VIII (2017-2028)
-
Figure Global Human Coagulation Factor VIII Market Size and Growth Rate of Plasma-derived Factor VIII (2017-2028)
-
Figure Global Human Coagulation Factor VIII Market Size and Growth Rate of Hemophilia A (2017-2028)
-
Figure Global Human Coagulation Factor VIII Market Size and Growth Rate of Spontanous / Trauma (2017-2028)
-
Figure Global Human Coagulation Factor VIII Market Size and Growth Rate of Surgical (2017-2028)
-
Figure Global Human Coagulation Factor VIII Market Size and Growth Rate of Other (2017-2028)
-
Figure North America Human Coagulation Factor VIII Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Human Coagulation Factor VIII Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Human Coagulation Factor VIII Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Human Coagulation Factor VIII Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Human Coagulation Factor VIII Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Human Coagulation Factor VIII Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Human Coagulation Factor VIII Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Human Coagulation Factor VIII Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Human Coagulation Factor VIII Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Human Coagulation Factor VIII Market Share, by Manufacturer in 2021
-
Figure Global and China Human Coagulation Factor VIII Market Share, by Manufacturer in 2022
-
Table Global Human Coagulation Factor VIII Sales Volume, by Type (2017-2028)
-
Table Global Human Coagulation Factor VIII Sales Volume Share, by Type (2017-2028)
-
Figure Global Human Coagulation Factor VIII Sales Volume Share, by Type (2017-2028)
-
Table Global Human Coagulation Factor VIII Sales Value, by Type (2017-2028)
-
Table Global Human Coagulation Factor VIII Sales Value Share, by Type (2017-2028)
-
Figure Global Human Coagulation Factor VIII Price Trend, by Type (2017-2028)
-
Table China Human Coagulation Factor VIII Sales Volume, by Type (2017-2028)
-
Table China Human Coagulation Factor VIII Sales Volume Share, by Type (2017-2028)
-
Figure China Human Coagulation Factor VIII Sales Volume Share, by Type (2017-2028)
-
Table China Human Coagulation Factor VIII Sales Value, by Type (2017-2028)
-
Table China Human Coagulation Factor VIII Sales Value Share, by Type (2017-2028)
-
Figure China Human Coagulation Factor VIII Price Trend, by Type (2017-2028)
-
Table Global Human Coagulation Factor VIII Sales Volume, by Application (2017-2028)
-
Table Global Human Coagulation Factor VIII Sales Volume Share, by Application (2017-2028)
-
Figure Global Human Coagulation Factor VIII Sales Volume Share, by Application (2017-2028)
-
Table Global Human Coagulation Factor VIII Sales Value, by Application (2017-2028)
-
Table Global Human Coagulation Factor VIII Sales Value Share, by Application (2017-2028)
-
Figure Global Human Coagulation Factor VIII Sales Value Share, by Application (2017-2028)
-
Table China Human Coagulation Factor VIII Sales Volume, by Application (2017-2028)
-
Table China Human Coagulation Factor VIII Sales Volume Share, by Application (2017-2028)
-
Figure China Human Coagulation Factor VIII Sales Volume Share, by Application (2017-2028)
-
Table China Human Coagulation Factor VIII Sales Value, by Application (2017-2028)
-
Table China Human Coagulation Factor VIII Sales Value Share, by Application (2017-2028)
-
Figure China Human Coagulation Factor VIII Sales Value Share, by Application (2017-2028)
-
Figure China Human Coagulation Factor VIII Production, Import, Consumption and Export (2017-2022)
-
Figure North America Human Coagulation Factor VIII Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Human Coagulation Factor VIII Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Human Coagulation Factor VIII Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Human Coagulation Factor VIII Production, Import, Consumption and Export (2017-2022)
-
Table North America Human Coagulation Factor VIII Sales Volume, by Type (2017-2028)
-
Table North America Human Coagulation Factor VIII Sales Volume Share, by Type (2017-2028)
-
Figure North America Human Coagulation Factor VIII Sales Volume Share, by Type (2017-2028)
-
Table North America Human Coagulation Factor VIII Sales Volume, by Application (2017-2028)
-
Table North America Human Coagulation Factor VIII Sales Volume Share, by Application (2017-2028)
-
Figure North America Human Coagulation Factor VIII Sales Volume Share, by Application (2017-2028)
-
Figure United States Human Coagulation Factor VIII Sales Volume and Growth Rate (2017-2028)
-
Figure United States Human Coagulation Factor VIII Sales Value and Growth Rate (2017-2028)
-
Figure Canada Human Coagulation Factor VIII Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Human Coagulation Factor VIII Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Human Coagulation Factor VIII Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Human Coagulation Factor VIII Sales Value and Growth Rate (2017-2028)
-
Table Europe Human Coagulation Factor VIII Sales Volume, by Type (2017-2028)
-
Table Europe Human Coagulation Factor VIII Sales Volume Share, by Type (2017-2028)
-
Figure Europe Human Coagulation Factor VIII Sales Volume Share, by Type (2017-2028)
-
Table Europe Human Coagulation Factor VIII Sales Volume, by Application (2017-2028)
-
Table Europe Human Coagulation Factor VIII Sales Volume Share, by Application (2017-2028)
-
Figure Europe Human Coagulation Factor VIII Sales Volume Share, by Application (2017-2028)
-
Figure Germany Human Coagulation Factor VIII Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Human Coagulation Factor VIII Sales Value and Growth Rate (2017-2028)
-
Figure UK Human Coagulation Factor VIII Sales Volume and Growth Rate (2017-2028)
-
Figure UK Human Coagulation Factor VIII Sales Value and Growth Rate (2017-2028)
-
Figure France Human Coagulation Factor VIII Sales Volume and Growth Rate (2017-2028)
-
Figure France Human Coagulation Factor VIII Sales Value and Growth Rate (2017-2028)
-
Figure Italy Human Coagulation Factor VIII Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Human Coagulation Factor VIII Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Human Coagulation Factor VIII Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Human Coagulation Factor VIII Sales Value and Growth Rate (2017-2028)
-
Figure Spain Human Coagulation Factor VIII Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Human Coagulation Factor VIII Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Human Coagulation Factor VIII Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Human Coagulation Factor VIII Sales Value and Growth Rate (2017-2028)
-
Figure Poland Human Coagulation Factor VIII Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Human Coagulation Factor VIII Sales Value and Growth Rate (2017-2028)
-
Figure Russia Human Coagulation Factor VIII Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Human Coagulation Factor VIII Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Human Coagulation Factor VIII Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Human Coagulation Factor VIII Sales Value and Growth Rate (2017-2028)
-
Table APAC Human Coagulation Factor VIII Sales Volume, by Type (2017-2028)
-
Table APAC Human Coagulation Factor VIII Sales Volume Share, by Type (2017-2028)
-
Figure APAC Human Coagulation Factor VIII Sales Volume Share, by Type (2017-2028)
-
Table APAC Human Coagulation Factor VIII Sales Volume, by Application (2017-2028)
-
Table APAC Human Coagulation Factor VIII Sales Volume Share, by Application (2017-2028)
-
Figure APAC Human Coagulation Factor VIII Sales Volume Share, by Application (2017-2028)
-
Figure China Human Coagulation Factor VIII Sales Volume and Growth Rate (2017-2028)
-
Figure China Human Coagulation Factor VIII Sales Value and Growth Rate (2017-2028)
-
Figure Japan Human Coagulation Factor VIII Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Human Coagulation Factor VIII Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Human Coagulation Factor VIII Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Human Coagulation Factor VIII Sales Value and Growth Rate (2017-2028)
-
Figure India Human Coagulation Factor VIII Sales Volume and Growth Rate (2017-2028)
-
Figure India Human Coagulation Factor VIII Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Human Coagulation Factor VIII Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Human Coagulation Factor VIII Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Human Coagulation Factor VIII Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Human Coagulation Factor VIII Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Human Coagulation Factor VIII Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Human Coagulation Factor VIII Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Human Coagulation Factor VIII Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Human Coagulation Factor VIII Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Human Coagulation Factor VIII Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Human Coagulation Factor VIII Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Human Coagulation Factor VIII Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Human Coagulation Factor VIII Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Human Coagulation Factor VIII Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Human Coagulation Factor VIII Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Human Coagulation Factor VIII Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Human Coagulation Factor VIII Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Human Coagulation Factor VIII Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Human Coagulation Factor VIII Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Human Coagulation Factor VIII Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Human Coagulation Factor VIII Sales Value and Growth Rate (2017-2028)
-
Table Baxter Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Baxter Product Profiles, Application and Specification
-
Table Baxter Human Coagulation Factor VIII Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Bayer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Bayer Product Profiles, Application and Specification
-
Table Bayer Human Coagulation Factor VIII Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table CSL Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table CSL Product Profiles, Application and Specification
-
Table CSL Human Coagulation Factor VIII Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Pfizer Product Profiles, Application and Specification
-
Table Pfizer Human Coagulation Factor VIII Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Grifols Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Grifols Product Profiles, Application and Specification
-
Table Grifols Human Coagulation Factor VIII Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Biogen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Biogen Product Profiles, Application and Specification
-
Table Biogen Human Coagulation Factor VIII Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Octapharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Octapharma Product Profiles, Application and Specification
-
Table Octapharma Human Coagulation Factor VIII Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table NovoNordisk Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table NovoNordisk Product Profiles, Application and Specification
-
Table NovoNordisk Human Coagulation Factor VIII Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Greencross Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Greencross Product Profiles, Application and Specification
-
Table Greencross Human Coagulation Factor VIII Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Kedrion Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Kedrion Product Profiles, Application and Specification
-
Table Kedrion Human Coagulation Factor VIII Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table BPL Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table BPL Product Profiles, Application and Specification
-
Table BPL Human Coagulation Factor VIII Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Hualan Bio Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Hualan Bio Product Profiles, Application and Specification
-
Table Hualan Bio Human Coagulation Factor VIII Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table RAAS Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table RAAS Product Profiles, Application and Specification
-
Table RAAS Human Coagulation Factor VIII Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
